Hiep Huatan
Vorstandsvorsitzender bei D3 Pharma Ltd
Profil
Hiep Huatan is currently the Managing Director at D3 Pharma Ltd, H2 Pharma Consulting Ltd., and a Member of the Royal Pharmaceutical Society of Great Britain.
Previously, he held positions as Vice President-Research & Development at Phoqus Pharmaceuticals Plc, Principal at Pfizer (St. Louis), and Chief Development Officer at Diurnal Group Ltd.
He holds a doctorate from The University of Manchester and an undergraduate degree from The University of Nottingham Malaysia Campus.
Aktive Positionen von Hiep Huatan
| Unternehmen | Position | Beginn |
|---|---|---|
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Corporate Officer/Principal | 08.01.2010 |
| H2 Pharma Consulting Ltd. | Vorstandsvorsitzender | - |
| D3 Pharma Ltd | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Hiep Huatan
| Unternehmen | Position | Ende |
|---|---|---|
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Corporate Officer/Principal | - |
| DIUL GROUP | Corporate Officer/Principal | - |
Phoqus Pharmaceuticals Plc
 Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Corporate Officer/Principal | - |
Ausbildung von Hiep Huatan
| The University of Manchester | Doctorate Degree |
| The University of Nottingham Malaysia Campus | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Phoqus Pharmaceuticals Plc
Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Health Technology |
Royal Pharmaceutical Society of Great Britain
Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Commercial Services |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
Diurnal Group Ltd.
 Diurnal Group Ltd. Pharmaceuticals: MajorHealth Technology Diurnal Group plc engages in the development of products for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia and adrenal insufficiency. It focuses on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena. The company was founded by Richard John Martin Ross in 2004 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
| D3 Pharma Ltd | |
| H2 Pharma Consulting Ltd. |
